Although inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021StrokeCardiologyOncologyGenitourinary CancerCancer
Pandemic-related drops in breast cancer screening hit hardest among medically underservedAugust 30, 2021Breast CancerOncologyWomen's HealthCancer
Use and Toxicity of Checkpoint Inhibitors for Solid Tumor Treatment in a Veteran PopulationAugust 25, 2021Oncology
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate CancerAugust 18, 2021Prostate CancerCancerOncology
An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care SystemAugust 18, 2021Colon and RectalOncologyPainMixed Topics
Comprehensive and Equitable Care for Vulnerable Veterans With Integrated Palliative, Psychology, and Oncology CareAugust 18, 2021OncologyMental HealthHospital Medicine
Three Primary Cancers in a Veteran With Agent Orange and Agent Blue ExposuresAugust 18, 2021OncologyMixed TopicsGenitourinary Cancer
25% of patients with cancer lack immunity against measlesAugust 13, 2021Infectious DiseasesVaccinesOncology
‘Routine’ use of focal therapy for prostate cancer in next 5 yearsAugust 11, 2021Genitourinary CancerOncology
Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerCancerOncology
The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration(FULL)August 2, 2021OncologyProstate Cancer
Integrating Germline Genetics Into Precision Oncology Practice in the Veterans Health Administration: Challenges and Opportunities (FULL)August 2, 2021Oncology
